182 related articles for article (PubMed ID: 33911720)
1. Exploratory Study of Epidermis, Basement Membrane Zone, Upper Dermis Alterations and Wnt Pathway Activation in Melasma Compared to Adjacent and Retroauricular Skin.
Espósito ACC; Brianezi G; de Souza NP; Miot LDB; Miot HA
Ann Dermatol; 2020 Apr; 32(2):101-108. PubMed ID: 33911720
[TBL] [Abstract][Full Text] [Related]
2. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
[TBL] [Abstract][Full Text] [Related]
3. Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.
Gautam M; Patil S; Nadkarni N; Sandhu M; Godse K; Setia M
Indian J Dermatol Venereol Leprol; 2019; 85(4):367-373. PubMed ID: 30516167
[TBL] [Abstract][Full Text] [Related]
4. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.
Torres-Álvarez B; Mesa-Garza IG; Castanedo-Cázares JP; Fuentes-Ahumada C; Oros-Ovalle C; Navarrete-Solis J; Moncada B
Am J Dermatopathol; 2011 May; 33(3):291-5. PubMed ID: 21317614
[TBL] [Abstract][Full Text] [Related]
5. Melasma: histopathological characteristics in 56 Korean patients.
Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural characterization of damage in the basement membrane of facial melasma.
Espósito ACC; Brianezi G; de Souza NP; Santos DC; Miot LDB; Miot HA
Arch Dermatol Res; 2020 Apr; 312(3):223-227. PubMed ID: 31531731
[TBL] [Abstract][Full Text] [Related]
7. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous Pathology of Melasma and Its Clinical Implications.
Kwon SH; Hwang YJ; Lee SK; Park KC
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240341
[TBL] [Abstract][Full Text] [Related]
9. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.
Miot LD; Miot HA; Polettini J; Silva MG; Marques ME
Am J Dermatopathol; 2010 Oct; 32(7):676-82. PubMed ID: 20534990
[TBL] [Abstract][Full Text] [Related]
10. Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study.
Espósito ACC; Brianezi G; de Souza NP; Miot LDB; Marques MEA; Miot HA
Int J Cosmet Sci; 2018 Aug; 40(4):420-424. PubMed ID: 29846953
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.
Lima EVA; Lima MMDA; Paixão MP; Miot HA
BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309
[TBL] [Abstract][Full Text] [Related]
12. Update on Melasma-Part I: Pathogenesis.
Espósito ACC; Cassiano DP; da Silva CN; Lima PB; Dias JAF; Hassun K; Bagatin E; Miot LDB; Miot HA
Dermatol Ther (Heidelb); 2022 Sep; 12(9):1967-1988. PubMed ID: 35904706
[TBL] [Abstract][Full Text] [Related]
13. Changes in nuclear morphology and chromatin texture of basal keratinocytes in melasma.
Brianezi G; Handel AC; Schmitt JV; Miot LD; Miot HA
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):809-12. PubMed ID: 24629163
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ex vivo melanogenic response to UVB, UVA, and visible light in facial melasma and unaffected adjacent skin.
Alcantara GP; Esposito ACC; Olivatti TOF; Yoshida MM; Miot HA
An Bras Dermatol; 2020; 95(6):684-690. PubMed ID: 33010989
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of melasma and implications for treatment.
Artzi O; Horovitz T; Bar-Ilan E; Shehadeh W; Koren A; Zusmanovitch L; Mehrabi JN; Salameh F; Isman Nelkenbaum G; Zur E; Sprecher E; Mashiah J
J Cosmet Dermatol; 2021 Nov; 20(11):3432-3445. PubMed ID: 34411403
[TBL] [Abstract][Full Text] [Related]
16. Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women.
Tamega Ade A; Miot HA; Moço NP; Silva MG; Marques ME; Miot LD
Int J Cosmet Sci; 2015 Apr; 37(2):222-8. PubMed ID: 25439299
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma.
Kang HY; Suzuki I; Lee DJ; Ha J; Reiniche P; Aubert J; Deret S; Zugaj D; Voegel JJ; Ortonne JP
J Invest Dermatol; 2011 Aug; 131(8):1692-700. PubMed ID: 21562572
[TBL] [Abstract][Full Text] [Related]
18. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.
Grimes PE; Yamada N; Bhawan J
Am J Dermatopathol; 2005 Apr; 27(2):96-101. PubMed ID: 15798432
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast morphology, growth rate and gene expression in facial melasma.
Espósito ACC; Brianezi G; Miot LDB; Miot HA
An Bras Dermatol; 2022; 97(5):575-582. PubMed ID: 35840442
[TBL] [Abstract][Full Text] [Related]
20. Role of fibroblast-derived factors in the pathogenesis of melasma.
Byun JW; Park IS; Choi GS; Shin J
Clin Exp Dermatol; 2016 Aug; 41(6):601-9. PubMed ID: 27416970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
